High Quality IVF Center in Israel – The Affordable Solution for Overseas Patients

Other Publications

You are here: Home » About Us » Other Publications

  • Kol S. First surrogacy pregnancy and delivery in Israel, Maariv, 23.2.1998. Full text
  • Kol S, Adashi EY. Intra-ovarian factors regulating ovarian function. Current Opinions in Obstetrics and Gynecology, 7:209, 1995. Full text
  • Kol S, Rohan RM and Adashi EY (2000). The role of growth factors in ovarian function and development. In: Sciarra JJ (Ed.), Gynecology and Obstetrics, Lippincott Williams and Wilkins, Philadelphia, PA. Vol. 5, 11:1-13. Full text
  • Itskovitz-Eldor J, Kol S. Disorders of the gonadotrophs. In: Reproductive Endocrinology, Surgery and Technology. Adashi EY, Rock JA, Rosenwaks Z Editors, Raven Press, NY (1996). Full text
  • Kol S, Itskovitz-Eldor J. Triggering ovulation with GnRH analogs. In: Serono Symposia. Ovulation: Evolving Scientific and Clinical Concepts. Eli Y. Adashi, Editor. Springer-Verlag, New York, Inc. 2000, pp. 308-316.
  • Kol S. Hormonal Therapy of the Infertile Woman. In: “Contemporary Endocrinology: Hormone Replacement Therapy”, second edition. Editor: Wayne Meikle, pp 525-536, 2003, Humana Press, Totowa, NJ. Full text
  • Kol S. Assisted Reproductive Technology. In: Encyclopedia of Endocrinology and Endocrine Diseases. Editor-in-Chief Luciano Martini, 2004, Academic Press, San Diego. California. Full text
  • Weissman A, Kol S, Peretz BA. Gas embolism in obstetrics and gynecology. J Reprod Med 41:103-111, 1996. Full text
  • Kol S, Adir Y, Shupak A, Stahl S. Adjuvant hyperbaric oxygenation therapy in hand edema and ischemia. Techniques in Hand and Upper Extremity Surgery 2:274-277, 1998. Full text
  • Kent-First MG, Kol S, Muallem A, Blazer S, Itskovitz-Eldor J. Infertility in intracytoplasmic-perm-injection-derived sons. Lancet 348:332, 1996. Full text
  • Kol S. Medical examination of rape victims. Medicine and Law 15:59, 1996. Full text
  • Kol S, Lewit N, Itskovitz-Eldor J. Ovarian hyperstimulation syndrome: modern concepts in pathophysiology and management. Mid East Fertil Soc J 1:246, 1996. Full text
  • Kol S. Oocyte donation: the shortage and a possible solution. Medicine and Law 19:74-77, 1998. Full text
  • Fertilization method is linked to gene defect. Washington Post, February 20, 1997. Full text
  • GnRH agonist instead of hCG to trigger ovulation in GnRH antagonist cycles. ESHRE Campus, Brussels, December 10th, 2004. GnRH antagonists in ovarian stimulation for IVF, Concensus workshop Group.
  • Kol S, Itskovitz-Eldor J. Society’s contribution to assisted reproductive technology abuse. Hum. Reprod. 20:2362, 2005. Full text
  • Kol S . Luteal support post GnRH agonist trigger: do not stop too soon. Human Reproduction 20:3257, 2005 Full text
  • Kol S. Does ovulation triggering influence the risk of OHSS? In “Ovarian Hyperstimulation Syndrome. Chapter 20. Edited by Gerris, Olivennes, Delvingne, Taylor&Francis. 2006 Full text
  • Kol S. Agonist trigger in the context of OHSS prevention: primum non nocere . Human Reproduction Update, advanced access published March 31, 2006. Full text
  • Kol S. GnRH agonist trigger: looking for the coin under the lamp post? Human Reproduction 21:1328, 2006. Full text
  • Prevention of OHSS. Serono Symposia, St. Petersburg, Russia, May 5-6, 2006. Microsoft Powerpoint presentation
  • Advanced age fertility: Can we improve the results? The 10th Annual Meeting of the Israeli Society for Community Gynecology, Israel, October 17, 2007. Microsoft Powerpoint presentation
  • Kol S Ultrasound-guided embryo transfer – a special role in patients with certain uterine defects. Fertil Steril. 2008, 89(1):260 Full text
  • Kol S The vanishing follicle in women aged over forty: Premature, mechanical, LH-independent luteinization may reflect oocyte-follicle low quality?Med Hypotheses. 2008 Jan 10Full text
  • R. Homburg, Kol S Letter to the Editor: Reply: Investigating actions of changing hormone levels. Human Reproduction, doi:10.1093/humrep/den307 Full text
  • Kol S. Does GnRHa triggering completely abolish OHSS? GnRH agonist for triggering of final oocyte maturation – time for a paradigm shift. ESHRE Campus, Madrid, Spain, 3 December 2010Microsoft Powerpoint presentation
  • Kol S, Rohan RM and Adashi EY (2008). The role of growth factors in ovarian function and development. In: The Global Library of Women’s Medicine. Full text
  • Kol S, A case of severe early-onset OHSS after GnRH-agonist triggering. Letter to the Editor. Fertil Steril. 96:e151, 2011 Full text
  • Kol S, (2011). Ovarian hyperstimulation prevention. In: The Global Library of Women’s Medicine Full text
  • Kol S, OHSS: Should this be treated or prevented? Asia Pacific COGI conference, Bangkok, Thailand, November 2011. COGI Bangkok Kol
  • P. Humaidan, S. Kol, E.G. Papanikolaou, L. Engmann, C. Benadiva, J. Itskovitz-Eldor, E.J. Margalioth, E. Ricciarelli, D. Bodri, J.C. Castillo-Farfan, J.A. Garcia-Velasco, C. Yding Andersen, P. Devroey and B. Tarlatzis. Reply:  GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum. Reprod. Update 2012 18: 229-230.  Full text
  •  Kol S. Prevention of OHSS. Updates in Infertility Treatment, Budapest, Hungary, 8-10 February, 2012.  PPTX presentation, Live lecture (video)
  • Kol S. GnRH-a to trigger ovulation should be used in all PCOS patients to prevent OHSS. COGI conference, Singapore, July 2012. PPTX presentation
  • Kol S. Individualized treatment from theory to practice: the private case of adding LH during GnRH antagonist based stimulation protocol. 11th Internatinal Symposium on GnRH, February 9-11, 2014, Salzburg, Austria.  PPTX presentation
  • Kol S.OHSS prevention: Yes, we can! 11th Internatinal Symposium on GnRH, February 9-11, 2014, Salzburg, Austria.  PPTX presentation
  • Kol S.IVF 2020, Maccabi Health Care, February 2014.  PPTX presentation
  • Kol S. GnRH agonist and individualized luteal phase hCG support will avoid OHSS in PCOS. Toward friendly stimulation in Assisted Reproductive Technology. Hillel Yafe, Hadera Israel, March 2014.  PPTX presentation
  • Kol S. Elonva in poor responders. WOOSP 2014, Jaipur India, August 6-10, 2014  PPTX presentation
  • Kol S. Luteal support post agonist trigger for OHSS prevention: The introduction of “luteal coasting” as a novel approach.. WOOSP 2014, Jaipur India, August 6-10, 2014  PPTX presentation
  • Kol S. Recombinant LH, recombinant hCG and GnRH agonist to trigger ovulation in antagonist cycles: a critical Evaluation. WOOSP 2014, Jaipur India, August 6-10, 2014  PPTX presentation,  video
  • Kol S. IVF in Israel, quality vs. quantity, Carmel Hospital, Haifa, Israel, October 2014  PPTX presentation
  • Kol S. Treatment strategies for the infertile PCO patient. COGI 2014, Ho Chi Minh City, Vietnam, November 20-22, 2014.  PPTX presentation
  • Kol S. Assisted Reproductive Technology (ART), Reference Module in Biomedical Sciences. Elsevier. 17-Oct-2014 doi:10.1016/B978-0-12-801238-3.03880-0.
  • Kol S. Luteal coasting post GnRH agonist trigger. COGI 2015, Frankfurt, Germany, May 14-16, 2015.  PPTX presentation
  • Kol S. Management of fertility treatment in PCOS patients. Update in Ob/Gyn, Leumit Sick Fund, Dead Sea, Israel, October 9, 2015.  PPTX presentation
  • Evron A, Blumenfeld Z, Adashi E, Kol S. The Role of Growth Factors in Ovarian Function and Development. Glob. libr. women’s med.,
    (ISSN: 1756-2228) 2015; DOI 10.3843/GLOWM.10288  Full text
  • Kol S. IVF results in Maccabi Health Services 2011-2014. Research Day, Maccabi-Assuta, Tel Aviv, January 2016 (Hebrew) PPTX presentation
  • Kol S. Regulatory guidelines for IVF: HBV and HCV infected individuals. The ABC for fertility treatments in carriers of hepatitis B&C. Special conference of AYALA, The Israel Fertility Association endorced by the IsASL, The Israel Association for the study of the liver, January 2016, Tel Aviv, (Hebrew) PPTX presentation
  • Kol S. LH and FSH surges for final oocyte maturation: Is dual surge beneficial?. in: Manual of ovulation induction & ovarian stimulation protocols, 3rd edition. Editors: Allahbadia and Merchant. Jaypee Brothers Medical Publishers, 2016, pp. 463-469.
  • Kol S. Quality measurement in IVF, Maccabi Health Care, March 2016.  PPTX presentation
  • Kol S. TV interview: IVF results in Israel, March 9th, 2016.  part 1.
     part 2.
  • Kol S. IVF treatment of high responders. Israel Fertility Association, School of Reproductive Endocrinology, April, 2016.  PPTX presentation
  • Kol S. Radio interview: “The experts”, Haifa Radio, June 6th, 2017. www.youtube.com/watch?v=5plZs_hcYMY link
  • Kol S. LH supplementation in antagonist protocol, November 17th, 2017. link
  • Kol S. Reducing implantation failure: novel approach to luteal phase support. Merck organised European Fertility Meeting (PERSONALISING THE PATIENT Journey in ART to SHORTEN TIME TO LIVE BIRTH) November 24th-25th, 2017 at Sheraton Congress Hotel, Frankfurt, Germany.  PPTX presentation
  • Kol S. A novel look at luteal phase support post IVF. XII International Congress on Reproductive Medicine, Moscow, Russia, 16-19.1.2018.  PPTX presentation
  • Kol S. The endocrinology of the luteal in IVF. Tel Aviv University, An Update in Fertility Treatments Symposium, June 15th, 2018. link
  • Kol S. The luteal phase: a new era. Israel Fertility Society meeting, January 2019.  PPTX presentation
  • Kol S. The roadmap to LH supplementation in IVF. Sociedade Portuguesa de Medicina da Reprodução. Porto, Portugal, May 10, 2019 (plenary).  PPTX presentation
  • Kol S. Prevention of OHSS: Modern Technique. The World Association of Perinatal Medicine, Novel approaches in Fertility and Ovulation, Dead Sea, Jordan, May 25th, 2019 (plenary).  PPTX presentation
  • Kol S. Treatment strategies in infertile PCOS. The World Association of Perinatal Medicine, Novel approaches in Fertility and Ovulation, Dead Sea, Jordan, May 25th, 2019 (plenary).  PPTX presentation
  • Kol S. Endometrial receptivity can be improved with luteal support fine-tuning. 1st World Congress on Women’s Health Innovations and Inventions (WHII): Addressing Unmet Needs. July 9-11, 2019 Tel Aviv, Israel.  PPTX presentation
  • Video clip, IVF Elisha, in Hebrew. link
  • Working together with the Jewish Fertility Foundation. link
  • Kol S. What kind and dose of gonadotropins to use? Are biosimilars an option?, EXCEMED, Improving success in ART, Tallinn, Estonia, 19 October 2019. (plenary).  PPTX presentation
  • Kol S. Triggering for ovulation – What are the options (hCG, GnRH a, Dual Triggering)?, EXCEMED, Improving success in ART, Tallinn, Estonia, 19 October 2019. (plenary).  PPTX presentation
  • Kol S. I-study: Continued medical education, Fertility: Ovulation triggering methods, and luteal phase support, first part. link
  • Kol S. I-study: Continued medical education, Fertility: Ovulation triggering methods, and luteal phase support, second part. link
  • Kol S. Natural pregnancy in advanced age (Hebrew). Tel Aviv University, February 21, 2020.  PPTX presentation
  • Kol S. The endocrinology of the luteal phase in IVF cycles (Hebrew), IVF Worldwide Webinar Series, April 6, 2020. link
  • Kol S. Radio Kol Chai interview October 15, 2020 (Hebrew).  Listen
  • Kol S. A wider spectrum in FSH and LH deficiency. The «6th Congress of the Hellenic Society of Fertility & Sterility». Thessaloniki, Greece, May 28-30, 2021, Satellite Symposium 1: Connecting the details for life.  PPTX presentation
  • Kol S. LH and FSH deficiency: personalization of controlled ovarian stimulation treatment. Potruguese Fertility Society Annual meeting, Merck symposium. September 24, 2021.
  • Kol S. Progesterone free luteal support in IVF. IVF Worldwide online congress, October 1-3, 2021.
  • Kol S. Severe LH and FSH deficiency in an infertile patient undergoing ART. Merck Mini-Symposium, Chateau du Lac, Genval, Belgium 4.10.2021.
  • Kol S. LH supplementation in ovarian stimulation for IVF: The individual, LH deficient, patient perspective. VITA NOVA 2021 Meeting, Bratislava, Slovakia, 21.10.2021.
  • Kol S. To add LH or not to add LH? Is this a personal question? 25th Brazilian Congress on Assisted Reproduction and 15th Red Latinoamericana de Reproducción Assistida, November 5, 2021.
  • Kol S. Poor prognosis patients and LH: from RCT’s and metanalyses to personalized medicine. 9th International IVIRMA Congress, Spain, Virtual Congress Week, November 15-19, 2021.
  • Kol S. Progesterone-free luteal support for IVF. 17th Annual conference of Indian Fertility Society, FERTIVISION 2021, 10th-12th December, 2021.
  • Kol S. Individualized LPS: Fresh and FET cycles. Turkish Society of Reproductive Medicine (TSRM): Evidence based approach in ART. September 17, 2022, Ankara, Turkiye.
  • Kol S. hCG as trigger: The good the bad and the alternative. Ferring Excahnges in Fertility (Scientific Committee), September 29-30, 2022, Copenhagen, Denmark.
  • Kol S. To add LH or not to add LH during ovarian stimulation, video clips, Buenos Aires Argentina, March 2022. links.
  • Kol S. LH supplementation and ART: For whom? Ho Chi Minh City, Vietnam, November, 2022.
  • Kol S. Time to personalize luteal phase support – fresh and FET cycles. Cappadocia, Turkiye, May 2023.
  • Kol S. Individualized LH supplementation in ovarian stimulation for IVF: Just a slogan or a reality. Athens, Greece, July, 2023.
  • Kol S. LH supplementation in IVF: It is all about endocrinology. Tartu. Estonia, 20.10.23.  PPTX presentation

IVF at Israel

With unbeatable success rates and an affordable, competitive price, IVF treatment in Israel enjoys popularity and prestige among overseas patients.